Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data CONSTELLIUM SE files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2022
FY2024
FY2024
FY2025
Revenue
8,532
7,826
7,335
8,449
Cost of revenue
7,569
6,771
6,397
7,262
Gross profit
963
1,055
938
1,187
Research and development
46
52
49
51
Selling, general and administrative
284
317
313
332
Interest expense
96
101
99
102
Pre-tax income
150
232
135
408
Income tax
-165
75
75
133
Net income to minority interests
7
5
4
2
Net income
308
152
56
273
EPS, basic
2.14
1.04
0.38
1.95
EPS, diluted
2.10
1.03
0.38
1.92
Shares, basic (weighted)
144
146
146
140
Shares, diluted (weighted)
147
148
148
142
Balance sheet
FY2022
FY2024
FY2024
FY2025
Cash and equivalents
176
223
141
120
Receivables
418
381
611
Inventory
1,197
1,181
1,407
Total current assets
1,992
1,834
2,322
Property, plant and equipment
2,422
2,408
2,585
Lease right-of-use assets
121
107
118
Goodwill
41
46
47
Intangible assets
104
97
88
Total assets
4,933
4,734
5,354
Accounts payable
1,025
959
1,222
Accrued liabilities
386
350
452
Deferred revenue
68
65
Short-term debt
41
39
39
Total current liabilities
1,556
1,446
1,798
Long-term debt
1,888
1,879
1,905
Lease liabilities
107
95
98
Total liabilities
4,191
4,007
4,383
Total debt
1,888
1,879
1,905
Paid-in capital
513
674
693
Retained earnings
93
354
Treasury stock
-51
-153
Other comprehensive income
0
-14
54
Shareholders' equity
718
706
952
Minority interests
24
21
19
Total equity
603
742
727
971
Total liabilities and equity
4,933
4,734
5,354
Shares outstanding
144
135
Cash flow statement
FY2022
FY2024
FY2024
FY2025
Net income
315
157
60
275
Depreciation and amortization
290
300
304
330
Stock-based compensation
18
22
25
19
Deferred income tax
-188
17
31
60
Change in receivables
73
-37
-50
-203
Change in inventory
-249
202
-24
-149
Change in payables
42
-206
-40
168
Cash from operations
365
432
301
489
Capital expenditures
-289
-366
-413
-330
Acquisitions
0
0
3
0
Cash from investing
-196
-216
-313
-309
Debt issued
0
0
671
0
Debt repaid
-202
-57
-689
-6
Share buybacks
0
0
-79
-115
Cash from financing
-150
-177
-61
-215
Exchange rate effect
-8
7
-9
14
Net change in cash
19
39
-73
-35
Free cash flow
76
66
-112
159
Interest paid
95
102
93
104
Income taxes paid
18
33
47
50
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to September 30, 2026; growth uses fiscal years. Valuation uses the share price of $22.47 on November 10, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
16.1%
Gross profit / revenue.
Pre-tax margin
8.1%
Pre-tax income / revenue.
Net margin
5.7%
Net income / revenue.
FCF margin
3.2%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
6.3%
Cash from operations / revenue.
Effective tax rate
28.9%
Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)
43.0%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
9.8%
Net income / average total assets.
R&D / revenue
0.5%
Research and development expense / revenue.
SG&A / revenue
3.6%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
0.3%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
3.2%
Capital expenditures / revenue.
D&A / revenue
3.3%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
15.2%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-0.3%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y
26.5%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
7.2%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y
387.5%
Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y
-3.9%
Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y
405.3%
EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y
-2.9%
Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y
62.5%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y
10.2%
Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 3y
27.9%
Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y
34.8%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
13.1%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
-4.1%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
-1.2%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.48x
Current assets / current liabilities.
Quick ratio
0.49x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.08x
(Cash + short-term investments) / current liabilities.
Debt / equity
1.33x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
30.4%
Total debt / total assets.
Liabilities / assets
77.1%
Total liabilities / total assets.
Net debt
$1.62B
Total debt - cash - short-term investments. Negative means more cash than debt.
Days inventory + days sales outstanding - days payables.
FCF conversion
55.6%
Free cash flow / net income, when net income is positive.
Capex / operating cash flow
50.0%
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
$4.13
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$72.30
Revenue / diluted weighted shares.
FCF per share
$2.30
Free cash flow / diluted weighted shares.
Operating cash flow per share
$4.59
Cash from operations / diluted weighted shares.
Book value per share
$9.92
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Share buybacks / free cash flow, when free cash flow is positive.
Valuation
Metric
Value
How it is calculated
Market cap
$3.05B
Share price x shares outstanding.
Enterprise value
$4.67B
Market cap + total debt - cash - short-term investments.
P/E
5.31x
Market cap / net income. Only when net income is positive.
P/S
0.30x
Market cap / revenue.
P/B
2.28x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
2.52x
Market cap / tangible book value, when positive.
P/FCF
9.55x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
4.77x
Market cap / cash from operations, when positive.
EV/Sales
0.46x
Enterprise value / revenue.
EV/FCF
14.6x
Enterprise value / free cash flow, when both are positive.
FCF yield
10.5%
Free cash flow / market cap.
Earnings yield
18.8%
Net income / market cap (the inverse of P/E).
Shareholder yield
3.9%
(Dividends paid + share buybacks) / market cap.
What was CONSTELLIUM SE's revenue in fiscal 2025?
CONSTELLIUM SE reported revenue of $8.45B for fiscal 2025, 15.2% higher than the year before.
Was CONSTELLIUM SE profitable in fiscal 2025?
Yes. Net income was $273.0M, a net margin of 3.2%.
How much free cash flow did CONSTELLIUM SE generate in fiscal 2025?
Cash from operations of $489.0M minus capital expenditures of $330.0M left free cash flow of $159.0M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.